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Park HC, Yasuda K, Kuo MC, Ni J, Ratliff B, Chander P,
Goligorsky MS. Renal capsule as a stem cell niche. Am J Physiol
Renal Physiol 298: F1254–F1262, 2010. First published March 3,
2010; doi:10.1152/ajprenal.00406.2009.—Renal resident stem cells
were previously reported within the renal tubules and papillary area.
The aim of the present study was to determine whether renal capsules
harbor stem cells and whether this pool can be recruited to the renal
parenchyma after ischemic injury. We demonstrated the presence of
label-retaining cells throughout the renal capsule, at a density of 10
cells/mm2, and their close apposition to the blood vessels. By flow
cytometry, in vitro cultured cells derived from the renal capsule were
positive for mesenchymal stem cell (MSC) markers (CD29, vimen-
tin, Sca-1, nestin) but did not express hematopoietic and endo-
thelial stem cell markers. Moreover, renal capsule-derived cells also
exhibited self-renewal, clonogenicity, and multipotency in differenti-
ation conditions, all favoring stem cell characteristics and identifying
them with MSC. In situ labeling of renal capsules with CM-DiI
CellTracker demonstrated in vivo a directed migration of CM-DiI-
labeled cells to the ischemic renal parenchyma, with the rate of
migration averaging 30 m/h. Decapsulation of the kidneys during
ischemia resulted in a modest, but statistically significant, deceleration
of recovery of plasma creatinine compared with ischemic kidneys
with intact renal capsule. Comparison of these conditions allows the
conclusion that renal capsular cells may contribute 25–30% of the
recovery from ischemia. In conclusion, the data suggest that the renal
capsule may function as a novel stem cell niche harboring MSC
capable of participating in the repair of renal injury.
renal mesenchymal stem cells; cell migration; renal ischemia
THE RECENT CROSS-DISCIPLINARY interest in stem cells has inevi-
tably raised questions related to structures harboring these
cells, stem cell niches. The classical examples of such niches
are represented by the bone marrow, crypts of the intestinal
microvilli, or reproductive organs like ovary and testis, all
providing a lifelong reservoir of stem cells capable of self-
renewal on the one hand and differentiation toward progenitor
and mature cells that are engaged in the maintenance of tissue
architecture on the other (14). Accordingly, niche environment
facilitates the asymmetric division of stem cells, shields them
from systemic signals capable of disrupting their properties,
and regulates their abundance. Zhang et al. (28) and Calvi et al.
(3) provided a comprehensive view of the bone marrow osteo-
blastic-hematopoietic stem cell (HSC) niche with its complex
regulation by parathyroid hormone and bone morphogenetic
protein. These studies have not only spurred the search for
other niches presumably present in each peripheral organ
throughout adulthood (8) but also identified many postnatal
tissues harboring mesenchymal stem cells (MSC) (7).
In the kidney, Oliver et al. (16) have demonstrated that
label-retaining cells are predominantly localized to the renal
papilla, the site characterized by reduced oxygen tension, from
where they are capable of migrating toward the sites of injury.
In addition, Maeshima et al. (13) and Challen et al. (4)
advocated the existence of a cortical tubular pool of stem cells,
suggesting the existence of another niche in the kidney.
Patschan et al. (17) detected nestin-expressing cells, presum-
ably corresponding in part to the MSC, located predominantly
in the corticomedullary zone and demonstrated their motility
and directed migration toward ischemic renal parenchyma.
One of the structures possessing a low metabolic rate and
oxygen tension and minimal fluctuations in physicochemical
parameters of the microenvironment and offering mechanical
protection by the surrounding adipose tissue is represented by
the renal capsule. This thin sheet of connective tissue contain-
ing fibroblasts, adipocytes, and blood vessels envelops the
kidney and has been considered as an inert barrier separating it
from the perinephric tissues. On the basis of the theoretical
prediction that this structure may represent a convenient res-
ervoir for pluripotent stem cells, we aimed to examine this
possibility. The search was also facilitated by the previous
demonstration of the presence of nestin-expressing cells in the
renal capsule, which provided an initial insight into this pos-
sibility (17). Here we present data on the phenotypic charac-
terization of the cells residing in the renal capsule and provide
evidence in favor of label-retaining capabilities of these cells,
their close apposition to the blood vessels, and their recruit-
ment to the injured renal parenchyma for potential participation
in regeneration of the kidney, all favoring the idea of renal
capsule serving as a niche for MSC.
METHODS
Animal studies. The animal study protocol was in accordance with
the National Institutes of Health (NIH) Guide for the Care and Use of
Laboratory Animals and approved by the Institutional Animal Care
and Use Committee of New York Medical College. Adult FVB/NJ
mice and Tie-2/GFP (green fluorescent protein) mice (on FVB/NJ
background) were purchased from the Jackson Laboratory (Bar Har-
bor, ME). Both groups of mice were labeled with bromodeoxyuridine
(BrdU) to detect label-retaining cells in the renal capsule, whereas
Tie-2/GFP mice were used for isolation and culture of renal capsule-
derived stem cells. FVB/NJ mice were also used for ischemia-
reperfusion (I/R)-induced mobilization studies. Sca-1/GFP mice were
obtained from Dr. M. P. Lisanti (Thomas Jefferson University) and
used only to identify Sca-1-GFPCD29 cells in the renal capsule.
Animals were kept under temperature-controlled conditions and a
12:12-h light-dark cycle, with water and food ad libitum.
In vivo BrdU labeling. To locate the cells in the renal capsule that
turned over at the slowest rate, we used a modified method for
labeling the renal capsule cells with BrdU (Sigma-Aldrich, St. Louis,
MO). Briefly, 4-wk-old FVB/NJ mice were subcutaneously injected
with a pulse of BrdU twice daily, at 9 AM and 4 PM, for 3.5
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consecutive days (50 g/g body wt) as described previously (16).
These mice were then followed for 2 mo (chase period) before I/R
experiments or death.
Immunodetection protocol. Kidneys of FVB/NJ mice previously
pulse labeled with BrdU and followed for 2 mo were harvested, fixed
in 4% paraformaldehyde (PFA) overnight at 4°C, washed three times
with PBS and transferred to PBS containing 30% sucrose (overnight
at 4°C), embedded in OCT (Tissue Tek; Sakura Finetek, Torrance,
CA), and stored at 80°C until analysis. Cryosections of kidney
tissues (10–20 m) were used for immunofluorescence analysis. In
separate studies, the renal capsules were carefully removed with
microforceps and processed separately for detection of label-retaining
cells. The capsules were fixed with 4% PFA at room temperature for
20 min and washed three times with PBS. After fixation, the renal
capsule was washed with PBS with 1% Triton X-100 and incubated in
2 N HCl for 30 min at 37°C. After that, HCl was immediately
neutralized by a 10-min wash with 0.1 M sodium borate and two
2-min washes with PBS. Capsules were then washed again with PBS
with 1% Triton X-100 at room temperature and subsequently incu-
bated for 1 h with a blocking solution (5% goat serum, 1 M glycine,
1% Triton X-100, PBS) to reduce nonspecific binding. The renal
capsules were stained with Alexa Fluor 488-conjugated mouse mono-
clonal primary antibody (dilution 1:20; Molecular Probes, Eugene,
OR) for 2 h at room temperature in a humidified chamber. Nuclei were
counterstained with 4=6-diamidino-2-phenylindole (DAPI). Double
immunofluorescence protocols using nestin (Rat-401, Developmental
Studies Hybridoma Bank, University of Iowa) and Ki-67 (rabbit
polyclonal, Abcam, Cambridge, MA) were used to assess character-
istics of BrdU-retaining renal capsule cells. The renal capsules from
Sca-1/GFP mice (C57 strain) were also stained with phycoerythrin
(PE)-conjugated anti-mouse CD29 (BD Pharmingen), a marker of
mesenchymal cell lineage. Images were obtained with a fluorescence
microscope (Eclipse TE2000-U) equipped with a digital camera (Spot
mode 4.2; Diagnostic Instruments, Sterling Heights, MI) or a Nikon
Eclipse C1 plus confocal microscope and EZ-C1 software version
3.60.
Isolation and culture of renal capsule-derived MSC. The adherent
cells derived from renal capsules of 3-mo-old male Tie-2/GFP mice
(FVB/NJ strain) were prepared as follows. Renal capsules were
aseptically removed, minced thoroughly with scissors, and partially
digested with collagenase I (1 mg/ml; Sigma) for 60 min at 37°C. The
cell suspension was washed with DMEM (Invitrogen) containing 10%
fetal bovine serum (FBS; Atlanta Biologicals) and filtered through a
40-m cell strainer (BD Falcon) to yield a single-cell suspension.
MSC were recovered from renal capsule cell suspension by their
tendency to adhere tightly to plastic culture dishes, as described
previously (18). Filtered renal capsule-derived cells were plated in
DMEM containing 10% FBS and penicillin-streptomycin (100 U/ml
and 0.1 mg/ml) and allowed to adhere for 24 h. Nonadherent cells
were removed, and the culture medium was exchanged every 3 days.
After confluence, cells were slowly frozen to 80°C in 7.5% DMSO,
after which the cells were thawed and grown to confluence. The freeze-
thaw cycle was repeated to remove remaining differentiated cell types, as
previously described (27). At confluence, the cells were propagated with
0.25% trypsin-0.02% EDTA solution (Invitrogen) and plated on 10-cm
dishes. Cells were used in the studies at passages 8–9.
Analysis of surface antigen expression of renal capsule-derived
cells by flow cytometry. Cultured renal capsule-derived cells were
stained with antibodies and analyzed by FACSCalibur (BD Bio-
sciences). In brief, 1  105 cells in PBS-1% BSA (wt/vol) were
incubated for 1 h at 4°C in the dark with PE-conjugated antibodies
(BD Biosciences) against CD31, CD34, Flk-1, c-Kit, Sca-1, CD150,
and CD29. Cells were permeabilized with 0.2% Triton X-100 and
incubated with monoclonal anti-rat nestin (Rat-401, Developmental
Studies Hybridoma Bank, University of Iowa) and monoclonal anti-
vimentin (clone LN-6, Sigma) antibodies. These cells were incubated
Fig. 1. Microvasculature and label-retaining cells in the mouse renal capsule. Mice were pulsed with bromodeoxyuridine (BrdU) for 3.5 days and followed for
8 wk. Renal capsules were carefully separated from renal parenchyma and analyzed by fluorescence microscopy. En face image of the isolated renal capsules
from Tie-2/GFP (green fluorescent protein ) mice (n  3) and mice pulsed with BrdU (n  5) demonstrated numerous microvasculatures (A) and BrdU-retaining
cells scattered throughout the renal capsules (C and D, arrows), respectively. The label-retaining cells showed some predilection for perivascular areas (E and
F, arrows). The renal capsules also demonstrated presence of nestin-positive cells (G). After acute ischemia-reperfusion (I/R) injury, some of the nestin-positive
cells were positive for Ki-67 (arrows), suggesting active proliferation (H). Scale bar, 50 m. A: GFP and 4=,6-diamidino-2-phenylindole (DAPI). C and
E: BrdU-FITC. D and F: BrdU-FITC  DAPI. G: nestin-FITC  DAPI. H: Ki-67-Texas red  nestin-FITC.
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with FITC- or Texas red-conjugated goat secondary antibodies (Jack-
son Immunoresearch). After each incubation step, cells were washed
with PBS-1% BSA (wt/vol) and finally fixed in 1% PFA. Flow
cytometry data were analyzed with CellQuest software (BD Bio-
sciences).
Clonogenic assay of renal capsule-derived cells. Renal capsule-
derived cells were plated at the density of 2 cells/cm2 on 100-mm
dishes coated with 10 g/ml pronectin (Sigma). Cells were cultured in
-minimal essential medium (-MEM; GIBCO/BRL, Carlsbad, CA)
with 10% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin for
15 days at 37°C and 5% CO2 without change of medium. The number
of formed colonies, defined as conglomerates consisting of at least 50
cells, was counted with a phase-contrast microscope (26).
In vitro differentiation assays of renal capsule-derived cells. To
determine whether renal capsule-derived cells maintain the multilin-
eage differentiation potential of mesenchymal cells, cells from pas-
sages 8–9 were cultured on pronectin-coated dishes. Undifferentiated
cells maintained a spindle-shaped morphology. Induction of osteo-
genic (2), adipogenic (19), and chondrogenic (12) differentiation was
performed according to previously reported methods with some mod-
ifications. Briefly, confluent cells were grown in serum-free DMEM
with insulin, transferrin, and selenium supplemented with hydrocor-
tisone (109 M), thyroxine (109 M), PGE1 (25 ng/ml; Sigma), and
transforming growth factor- (TGF-, 5 ng/ml; Peprotech, Rocky
Hill, NJ). Osteoblastic differentiation was induced by culturing con-
fluent mouse renal capsule cells for 3 wk in serum-free medium
supplemented with 10 mM -glycerophosphate and 0.3 mM ascorbic
acid (all from Sigma). Culture medium was exchanged every 2 days
to overcome the instability of ascorbic acid in neutral pH. Cells were
fixed for 15 min in ice-cold PFA before labeling for alkaline phos-
phatase activity and von Kossa stain for calcified matrix. Adipocytic
differentiation was induced in cultured renal capsule cells grown at
low density in serum-free medium with 106 M hydrocortisone for 2
wk with medium exchange every 3–4 days. Cells were fixed and
stained for lipid droplets with Oil Red O (Sigma). To induce chon-
drocytic differentiation, confluent renal capsule cells were cultured for
3 wk in serum-free medium supplemented with TGF- (10 ng/ml),
hydrocortisone (107 M), sodium pyruvate (1 mM), 2-phosphate
ascorbic acid (1.7  104 M), and proline (35 mM) (all from Sigma).
Medium was exchanged every 2–3 days for 3 wk before staining with
Alcian blue (Sigma). Endothelial differentiation was induced by
growth on Matrigel-coated dishes in serum-free medium supple-
mented with VEGF (10 ng/ml) and FGF-2 (50 ng/ml) (Sigma) for 1
wk (20). Cells were identified by capillary-like tube formation and
expression of CD31 by immunohistochemistry.
In situ renal capsule labeling with CM-DiI and mobilization of
renal capsule-derived cells during I/R injury. Unilateral renal ische-
mia in male 12-wk-old FVB/NJ mice was performed according to a
previously detailed protocol (5). Briefly, renal ischemia was created
by clamping the left renal pedicle with microserrefines (Fine Science
Tools, Foster City, CA) placed for 30 min. Renal capsules of both
ischemic and nonischemic kidneys were carefully coated with red
fluorescent CM-DiI (Invitrogen) according to the manufacturer’s
instructions. After 30 min of labeling, the excess CM-DiI was washed
Fig. 2. Characteristics of renal capsule-derived cells. A: representative phase-contrast micrograph shows spindle-shaped morphology of cultured renal
capsule-derived cells. B: merged immunofluorescent image of renal capsule bearing a cell dual-positive for Sca-1/GFP and CD29-phycoerythrin (PE). C: cloning
efficiency derived from 5 independent experiments was 6.7 	 0.9%. D: FACS analyses show that renal capsule-derived cells were positive for surface markers
characteristic of mesenchymal stem cells (MSC) (CD29, vimentin, nestin, Sca-1) and were negative for hematopoietic or endothelial progenitor cell markers
(CD31, CD34, Flk-1, CD150, and CD117). The respective isotype controls are also shown (empty histograms).
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with sterile PBS. Throughout the procedure, the abdomen was cov-
ered with gauze moistened in PBS, and animals were kept well
hydrated with saline and at a constant temperature (37°C) with a
heated thermoplate (Tokai Hit, Fujinomiya-shi, Shizuoka-ken, Japan).
Mice were killed on days 1 and 3 and 4 wk after renal I/R injury. The
kidneys were harvested and fixed in 4% PFA overnight at 4°C,
transferred to PBS containing 30% sucrose (overnight at 4°C), em-
bedded in OCT (Tissue Tek; Sakura Finetek), and stored at 80°C.
Cryosections (10 m) were used for immunofluorescent analysis.
Mobilization of renal capsule-derived cells during renal I/R injury was
identified by detecting red fluorescent CM-DiI-labeled cells in the
renal parenchyma by fluorescence microscopy. The renal tissues were
also stained for -smooth muscle actin (-SMA, clone 1A4, Sigma)
and appropriate secondary antibody to identify the possible origin and
fate of CM-DiI-labeled cells.
Functional effect of renal capsule removal in I/R injury. Bilateral
renal ischemia was performed in a separate group of 12-wk-old male
FVB/N mice with the experimental protocol described above. For the
decapsulation group, renal capsules were gently stripped from both
kidneys with microforceps (see Supplemental Data for surgery movie).1
Serum creatinine was measured on days 1, 2, and 3 after I/R injury in
both groups of mice to assess the functional effects of renal capsule
removal. Renal capsules were removed in another batch of mice, and
their histology and serum creatinine levels were compared with those
of a group of mice that underwent sham operation.
Statistical analysis. Data are presented as means 	 SE, and
statistical significance was assessed by two-tailed Student’s t-test. A
P value 
0.05 was considered to be statistically significant.
RESULTS
Immunodetection of BrdU-retaining cells in mouse renal
capsule. Previous studies observed the presence of slow cy-
cling, label-retaining cells in the adult kidney (13, 16, 25).
Nestin-GFP-expressing mice showed comparable findings
(17). To investigate whether slow cycling cells are also present
within the renal capsule, mice were pulse-labeled with BrdU
and the presence of label-retaining cells in the renal capsule
was investigated by immunofluorescence microscopy. The re-
nal papillary area demonstrated some BrdU-retaining cells,
whereas label-retaining cells were rarely observed in the cor-
tical areas (data not shown) as previously described (16).
Imaging of the isolated and whole-mounted en face renal
capsules demonstrated numerous microvasculatures in the re-
nal capsules (Tie-2/GFP mice, n  3, Fig. 1A) along with
label-retaining cells scattered throughout the renal capsule (n  5,
12.1 	 1.1 cells/mm2, Fig. 1, B–D). Enumeration of BrdU-
labeled cells was performed on the entire recovered renal
capsules, and only heavily BrdU-immunostained nuclei were
counted as labeled cells. The label-retaining cells showed a
predilection for perivascular areas (Fig. 1, E and F). The renal1 The online version of this article contains supplemental material.
Fig. 3. Multilineage differentiation potential of renal capsule-derived MSC. A: micrographs of control cells. B: adipogenic differentiation showing the presence
of lipid droplets by Oil Red O stain after 2 wk of culture in adipogenic differentiation medium. C: calcium deposition detected by von Kossa stain after culture
of renal capsule-derived MSC in osteogenic medium for 3 wk. D: chrondrogenic differentiation shown by formation of pellet positive for Alcian blue after culture
in chondrogenic medium for 3 wk. E and F: micrographs showing spontaneous formation of capillary tube-like structures within 1 wk of culture on Matrigel
supplemented with EGM-2 medium (E) and rare GFP-positive cells after 4 wk of culture in EGM-2 medium (F). Results are representative of 3 independent
experiments.
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capsules also demonstrated the presence of nestin-positive cells
(Fig. 1G). Some of these nestin-positive cells were also posi-
tive for Ki-67 after acute I/R injury (but rarely in the intact
kidneys), suggesting active proliferation (Fig. 1H and see
below).
Immunophenotypic characterization and self-renewal ca-
pacity of renal capsule-derived cells. The renal capsules were
carefully separated from the kidneys and perinephric adipose
tissue as described in METHODS. Isolated renal capsules were
then collagenase dispersed, and cells were plated on gelatin-
coated dishes. After 4 wk in culture, most of the cells derived
from renal capsule became spindle shaped (Fig. 2A). FACS
analysis showed that cultured renal capsule-derived cells were
positive for CD29 (99%), vimentin (97%), Sca-1 (86%), and
nestin (87%) but negative for CD31, CD34, Flk-1, CD150, and
CD117, identifying them as MSC (Fig. 2B). The self-renewal
capacity of the MSC derived from renal capsules was assessed
by the limiting dilution method, and the cloning efficiency was
6.7 	 0.9%. These cells were subcultured for 50 generations
without loss of proliferative capacity.
In vitro differentiation of renal capsule-derived MSC. Be-
cause the defining characteristic of MSC is their ability to
differentiate into multiple mesenchymal lineages, we examined
the ability of renal capsule-derived cells to differentiate into
specific interstitial cells. Renal capsule-derived cells could be
induced to differentiate into adipocytes, osteocytes, and chon-
drocytes in the appropriate inductive microenvironment within
2–3 wk (Fig. 3). Moreover, culturing renal capsule-derived
cells on Matrigel in EGM-2 medium resulted in capillary tube
formation within 3 days. However, very few cells were stained
positive for CD31 (endothelial differentiation) even after 4 wk
of culture in EGM-2 medium, suggesting a less efficient
differentiation into endothelial cells.
Mobilization of renal capsule-derived cells during I/R
injury. To investigate in vivo whether cells residing in the renal
capsule can migrate into the renal parenchyma, fluorescent
Fig. 4. Mobilization of renal capsule-derived cells into
injured renal parenchyma during I/R injury. A: schema
for in situ labeling of renal capsule with filter paper
soaked in the fluoroprobe CM-DiI. B: acute I/R injury
resulted in migration of in situ CM-DiI-labeled renal
capsule cells (arrows) into renal parenchyma, with pref-
erential homing to injured perivascular space. C: non-
ischemic contralateral control kidney shows CM-DiI
labeling confined to renal capsule without any migra-
tion. D and E: degree (D) and distance (E) of mobilized
CM-DiI-labeled cells were comparable between day 1
and day 3 after I/R injury. Each result is representative
of 4 independent experiments. RK, right kidney; LK,
left kidney.
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CM-DiI was used as an in situ cell labeling marker. The renal
capsules were labeled with CM-DiI through direct contact with
filter paper soaked in the fluoroprobe, and unilateral I/R injury
was induced in FVB/NJ mice (Fig. 4A). Renal sections were
examined by serial immunofluorescence microscopy. Acute
I/R injury resulted in migration of in situ CM-DiI-labeled cells
(red fluorescence) derived from prelabeled renal capsules into
the renal parenchyma of ischemic, but not contralateral, kid-
neys (Fig. 4B). In the nonischemic control kidneys, CM-DiI-
labeled cells remained confined to renal capsule and showed no
migration (Fig. 4C). The number of migrating cells and mi-
gratory distances of CM-DiI-labeled cells found in the renal
parenchyma were comparable on day 1 and day 3 after I/R
injury (n  4 for each time period, 2.3 	 0.4 vs. 2.7 	 0.5
cells/mm2 and 987 	 218 vs. 868 	 312 m). This would
account for the rate of migration averaging at least 30 m/h,
comparable to what was described ex vivo. These data suggest
that cells originating from the renal capsule migrate into the
renal parenchyma early after I/R injury.
The kidneys were stained with antibodies for -SMA and
carefully examined for cells expressing both -SMA and
CM-DiI. None of the CM-DiI-labeled cells observed on day 3
after ischemic injury was positive for -SMA, suggesting that
they are not capsule-derived myofibroblasts. Furthermore,
when the fate of CM-DiI-labeled cells was examined at 4 wk,
none of them expressed immunodetectable -SMA, suggesting
that these cells also do not differentiate into myofibroblasts
(Fig. 5).
The question that emerged was whether these migrating cells
represent a progeny of or original renal capsular stem cells. To
address this question, we stained renal parenchyma from con-
trol and ischemic kidneys for the expression of the proliferation
Fig. 5. Fate of mobilized renal capsule-derived cells after I/R injury: representative images of kidney sections of mice that underwent capsular CM-DiI labeling
followed by I/R injury and were killed on days 3, 14, and 28 after I/R injury as described in METHODS. A–C: kidney sections were stained with -smooth muscle
actin (-SMA) and appropriate secondary FITC antibody and carefully assessed by epi-immunofluorescence. None of the CM-DiI-labeled cells (arrows)
coexpressed FITC. Left: original magnification was 400. Each result is representative of 4 independent experiments.
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marker Ki-67 in BrdU pulse-chase experimental mice. As
shown in Fig. 6, there was no detectable surge in the prolifer-
ation of label-retaining cells in the postischemic kidneys.
These data suggest that migrating cells represent, most likely,
the original stem cells residing in the renal capsule. The
absence of detectable cell division of cells migrated from the
capsule to the interstitium may point to the predominantly
paracrine proregenerative action of these cells; alternatively, it
may be argued that the contribution of these cells is relatively
small (25–30%) and therefore any potential increase in their
proliferation remains below the limits of detection.
Effect of decapsulation in course of acute kidney injury. The
functional effect of renal capsule removal was assessed by
performing bilateral renal ischemia with or without decapsu-
lation. The initial rise in serum creatinine was not significantly
different between the control group and the decapsulated
group, suggesting that stripping procedures per se did not
increase the renal vulnerability to acute ischemic injury.
However, there was a modest but statistically significant
favorable course of recovery in the control group on day 3
after ischemic injury versus the ischemia  decapsulation
group (% decrease in serum creatinine level from day 0 to
day 3: 46.0 	 6.1% vs. 27.9 	 3.5%, P  0.027, respec-
tively; Fig. 7), suggesting in vivo significance of renal
capsule-derived stem cells.
DISCUSSION
The present study provides first evidence that BrdU-retain-
ing, slow-cycling, nestin-expressing cells exist in the renal
capsule and cells cultured from renal capsule express epitopes
and intracellular markers characteristic of MSC. Furthermore,
cells originating from renal capsule migrate into renal paren-
chyma after I/R injury, suggesting their participation in renal
repair process.
Several criteria need to be fulfilled in describing cell “stem-
ness.” These include a near-unlimited proliferative capacity,
clonogenicity, multipotency, and expression of consensus
markers. These were all met in the case of MSC derived from
Fig. 6. No detectable proliferation of label-retaining cells in the renal parenchyma after ischemia. Left: representative images of proliferating (Ki-67-Texas red
positive) (top) and BrdU-FITC-labeled (bottom) cells in control and ischemic kidneys. Right: quantification of the numbers of proliferating (top) and
label-retaining (bottom) cells. Each result is representative of 4 independent experiments. HPF, high-power field.
Fig. 7. Effect of decapsulation in the course of acute I/R injury. Mechanical
stripping of the renal capsules did not increase the kidney’s vulnerability to
acute I/R injury. However, the decapsulated group showed slower renal
functional recovery compared with the control group (*vs. day 1, #vs. control
group, P  0.043).
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the renal capsule. These cells were subcultured for 50 gen-
erations without loss of proliferative ability; they possessed
clonogenic properties. Cells also showed in vitro ability to
differentiate into various interstitial lineages when cultured in
induction media (osteogenic, chondrogenic, and adipogenic).
In addition, renal capsular cells expressed CD29 (99%), vi-
mentin (97%), Sca-1 (86%), and nestin (87%), all markers of
MSC (10).
Recent studies have identified various tissues harboring
novel stem cell niches (7, 11, 21, 22). Epicardium, a layer of
epithelial cells enveloping the myocardium, has been reported
to contain a cell population with stem cell characteristics
(c-kit and CD34). Myocardial ischemia induced the epi-
cardial c-kit cell proliferation and their differentiation into a
myocardial and endothelial phenotype, thus giving rise to
myocardial and vascular precursor cells (11). Furthermore,
CD24 CD133 cells isolated from Bowman’s capsule were
shown to not only possess stem cell phenotypic characteristics
but also provide in vivo renoprotection in functional kidney
damage (21). These findings, together with our data, provide
support for existence of a renal capsular stem cell niche and
potentially open areas for regenerative medicine in renal dis-
eases.
Migration was observed in papillary stem cells (16), in
nestin-GFP cells (17), and in renal capsule MSC (this study)
after ischemic insult. Among the guidance cues for migration
stromal cell-derived factor-1 (SDF-1) plays a prominent role,
and ischemic kidney represents a rich source for this chemoat-
tractant (23). The rate of migration is comparable to that
measured ex vivo in nestin-GFP mice (17). The fact that MSC
residing in the renal capsule are capable of infiltrating renal
parenchyma may be indicative of their participation in kidney
regeneration, because previous studies performed in our and
other laboratories documented the ability of MSC to rescue the
kidney after ischemic insult (5, 9, 24). The pericyte-like prop-
erties of MSC have been noted and recently summarized (1, 6,
15). In this context, cells in the renal capsule displayed an
inconspicuous predilection to the microvasculature, clustering
around the vessels in a manner similar to the pericytes. It
remains unknown how these cells traverse the capsule-paren-
chyma boundary in the case of ischemia; however, it is quite
possible that they utilize small nutritive arterioles as conduits
for this egress.
There are several issues that need future investigation. First,
genetic fate tracing analysis would be needed to definitively
prove the origin of renal capsule-derived stem cells and their
potential progeny infiltrating ischemic renal parenchyma. Sec-
ond, the in vitro differentiation assays conducted in this study
used nonhomogeneous renal capsule-derived cells pooled from
culture experiments (not from a single colony). Therefore, the
present differentiation results do not demonstrate the true
potential of a homogeneous clonally expanded renal capsule-
derived cell. However, differentiation was observed in the
majority of cells cultured in each of the induction media,
suggesting that the bulk of cells have the capacity to differen-
tiate into mesenchymal lineages.
In conclusion, several lines of presented evidence identify
the renal capsule as a potential stem cell niche. It serves as a
reservoir for MSC, “universal repair cells in adult tissues” (1),
which are quiescent under normal conditions but become
recruited to the renal parenchyma after renal ischemia. Further
work will be required to firmly establish the origin of these
cells and trace their migratory pathways.
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